Iambic Announces Pricing of Initial Public Offering
Iambic official newsroom · 行業原文收錄 · 來源發佈:Wed Oct 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 本站收錄:Thu Oct 15 2026 00:07:40 GMT+0000 (Coordinated Universal Time)
已保存的原文節選
SAN DIEGO, Calif., October 14, 2026 – Iambic Therapeutics, Inc. (Iambic) (Nasdaq: IAM), a clinical-stage life sciences and technology company advancing novel medicines using its AI-driven platform, today announced the pricing of its initial public offering of 9,375,000 shares of common stock at a public offering price of $16.00 per share. All of the shares of common stock are being offered by Iamb
以上為帶出處的原文節選,完整內容請閱讀原始鏈接。自動收錄與主題分類不等於事實核驗。